Implantable continuous glucose sensors

Current Diabetes Reviews

Volumn 4, Issue 3, 2008, Pages 169-174

  Renard, Eric ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Closed loop insulin delivery; Continuous blood glucose monitoring; Diabetes mellitus; Glucose sensors; Implantable devices

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOSE; INSULIN;

BLOOD FLOW; BLOOD GLUCOSE MONITORING; CALIBRATION; CLINICAL TRIAL; DEVICE; DIAGNOSTIC ACCURACY; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPLANTATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LOW DRUG DOSE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSOR; SHEAR STRENGTH; TISSUE REACTION;

ANIMALS; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DOGS; EQUIPMENT DESIGN; HUMANS; MODELS, ANIMAL; MONITORING, PHYSIOLOGIC; PROSTHESES AND IMPLANTS; USER-COMPUTER INTERFACE;

EID: 54749139734     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339908785294406     Document Type: Review

References (21)

1. Renard E. Monitoring glucose control: the importance of self-monitoring of blood glucose. Am J Med 2005; 118 (9A): 12-9S.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
3. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
4. Hanaire-Broutin H. Insulin therapy and self-monitoring of blood glucose: therapeutic management and recommendations. Diabetes Metab 2003; 29 (2 Pt 2): S21-5.
5. Renard E. Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? Diabetes Metab 2003; 29 (2 Pt 2): S54-62.
6. Renard E. Implantable glucose sensors for diabetes monitoring. Min Invas Ther Allied Technol 2004; 13: 78-86.
7. Pickup JC, Hussain F, Evans ND, Sachedina N. In vivo glucose monitoring: the clinical reality and the promise. Biosens Bioelectron 2005; 20: 1897-1902.
8. Daniloff GY. Continuous glucose monitoring: long-term implantable sensor approach. Diabetes Technol Ther 1999; 1: 261-6.
9. Pickup JC, Hussain F, Evans ND, Rolinski OJ, Birch DJS. Fluorescence-based glucose sensors. Biosens Bioelectron 2005; 20: 2555-65.
10. Wentholt IME, Hart AAM, Hoekstra JBL, Devries JH. Relationship between interstitial and blood glucose in type 1 diabetes patients: delay and the push-pull phenomenon revisited. Diabetes Technol Ther 2007; 9: 169-75.
11. Kulcu E, Tamada JA, Reach G, et al. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003; 26: 2405-9.
12. Renard E. Implantable closed loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2002; 2: 708-16.
13. Hanaire H. Continuous glucose monitoring and external insulin pump: toward a subcutaneous closed loop. Diabetes Metab 2006; 32 (5 Pt 2): 534-8.
14. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000; 23: 208-14.
15. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004; 27: 734-8.
16. Jaremko J, Rorstad O. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 1998; 2: 444-50.
17. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular glucose sensor in dogs. Diabetes 1990; 39: 1519-26.
18. Gough DA, Armour JC, Baker DA. Advances and prospects in glucose assay technology. Diabetologia 1997; 40(Suppl 2): S102-7.
19. Steil GM, Panteleon AE, Rebrin K. Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev 2004; 56: 125-44.
20. Renard E, Costalat G, Chevassus H, Bringer J. Artificial beta cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab 2006; 32: 497-502.
21. Renard E, Costalat G, Chevassus H, Bringer J. Closed loop insulin delivery using implanted insulin pumps and sensors in type 1 diabetic patients. Diabetes Res Clin Pract 2006; 74 (Suppl 2): S173-7.